Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Packer

Showing results (321-330 of 4,797) with videos related to

Pageof 480
Sort By:
European Journal of Heart Failure|June 12, 2018
Risk of heart failure in diabetic patients receiving sulfonylureas: replyMilton Packer
European Heart Journal|May 14, 2019
Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillationMilton Packer
Modern Healthcare|July 29, 1991
Bill seeks closer tracking of waste sent through mailJ Packer
The American Journal of Medicine|May 4, 2001
Current role of beta-adrenergic blockers in the management of chronic heart failureM Packer
Australasian Physical & Engineering Sciences in Medicine|January 5, 2002
Verification of ophthalmic brachytherapy treatment planningK Packer
Journal of Cardiac Failure|November 14, 2025
Is It Time to Abandon Phenomapping of Heterogeneity to Elucidate the Mechanisms or Define the Treatment of Heart Failure with a Preserved Ejection Fraction?Milton Packer
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2023
Alleviation of Anemia by SGLT2 Inhibitors in Patients with CKD: Mechanisms and Results of Long-Term Placebo-Controlled TrialsMilton Packer
Science (New York, N.Y.)|September 16, 1983
Sexual dimorphism: the horns of african antelopesC Packer
American Heart Journal|December 1, 1990
The placebo effect in heart failureM Packer
Circulation. Heart Failure|September 22, 2011
Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent diseaseMilton Packer
Pageof 480

Showing results (321-330 of 4,797) with videos related to

Sort By:
Pageof 480
European Journal of Heart Failure|June 12, 2018
Risk of heart failure in diabetic patients receiving sulfonylureas: replyMilton Packer
European Heart Journal|May 14, 2019
Effect of catheter ablation on pre-existing abnormalities of left atrial systolic, diastolic, and neurohormonal functions in patients with chronic heart failure and atrial fibrillationMilton Packer
Modern Healthcare|July 29, 1991
Bill seeks closer tracking of waste sent through mailJ Packer
The American Journal of Medicine|May 4, 2001
Current role of beta-adrenergic blockers in the management of chronic heart failureM Packer
Australasian Physical & Engineering Sciences in Medicine|January 5, 2002
Verification of ophthalmic brachytherapy treatment planningK Packer
Journal of Cardiac Failure|November 14, 2025
Is It Time to Abandon Phenomapping of Heterogeneity to Elucidate the Mechanisms or Define the Treatment of Heart Failure with a Preserved Ejection Fraction?Milton Packer
Clinical Journal of the American Society of Nephrology : CJASN|October 30, 2023
Alleviation of Anemia by SGLT2 Inhibitors in Patients with CKD: Mechanisms and Results of Long-Term Placebo-Controlled TrialsMilton Packer
Science (New York, N.Y.)|September 16, 1983
Sexual dimorphism: the horns of african antelopesC Packer
American Heart Journal|December 1, 1990
The placebo effect in heart failureM Packer
Circulation. Heart Failure|September 22, 2011
Can brain natriuretic peptide be used to guide the management of patients with heart failure and a preserved ejection fraction? The wrong way to identify new treatments for a nonexistent diseaseMilton Packer
Pageof 480